ISR

ISORAY
AMEX

实时行情|Nasdaq Last Sale

0.5519
-0.0187
-3.28%
休市 16:00 03/27 EDT
开盘
0.5800
昨收
0.5706
最高
0.5900
最低
0.5425
成交量
10.02万
成交额
--
52周最高
1.060
52周最低
0.2875
市值
3,733.63万
市盈率(TTM)
-9.4181
分时
5日
1月
3月
1年
5年

分析师评级

3位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测ISR价格均价为1.383,最高价位1.500,最低价为1.250。

EPS

ISR 新闻

更多
  • 朝“虑”夕改 特朗普称没必要对纽约等三州进行隔离
  • 央视 · 2小时前
  • 澳大利亚专家反思:应该更早对美国实施边境禁入
  • 央视 · 3小时前
  • 美媒:佩洛西与特朗普“冷战”5个多月
  • 新华网 · 4小时前
  • 美联储无底线量宽后 美股“黎明前的黑暗”来了吗
  • 经济观察报 · 6小时前

所属板块

生物技术和医学研究
-2.43%
制药与医学研究
-0.87%

热门股票

代码
价格
涨跌幅

ISR 简况

IsoRay, Inc. is a medical technology company. The Company, through its subsidiary, IsoRay Medical, Inc., develops, manufactures and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases. The Company is engaged in the production and sales of Cesium-131 (Cs-131) brachytherapy seeds. Brachytherapy seeds are small devices containing a therapeutic dose of radiation used in an interstitial radiation procedure. The brachytherapy procedure places radioactive seeds as close as possible to (in or near) the cancerous tumor. The Cs-131 includes radioisotope in the treatment of all malignant tumors, such as prostate cancer, brain cancer, breast cancer, colorectal cancer, gynecological cancer, lung cancer, liver cancer, ocular melanoma and pancreatic cancer. The Company's Proxcelan Cesium-131 seed is classified as a Class II device.
展开

微牛提供IsoRay, Inc.(AMEX-ISR)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的ISR股票新闻,以帮助您做出投资决策。